BeOne Medicines (ONC) Minority Interest (2017 - 2020)

BeOne Medicines (ONC) has 4 years of Minority Interest data on file, last reported at $19.6 million in Q3 2020.

• Quarterly Minority Interest rose 24.37% year-over-year to $19.6 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $19.6 million (up 24.37% YoY) and the FY2019 annual result came in at $16.2 million, up 11.8% from the prior year.
• Minority Interest climbed to $19.6 million in Q3 2020 per ONC's latest filing, from $10.2 million in the prior quarter.
• Across five years, Minority Interest topped out at $19.6 million in Q3 2020 and bottomed at $10.2 million in Q2 2020.
• The 4-year median for Minority Interest is $14.4 million (2017), against an average of $14.7 million.
• The widest annual swing landed in 2019, when Minority Interest increased 29.07%; it then plunged 41.37% in 2020.
• Tracing ONC's Minority Interest over 4 years: stood at $14.4 million in 2017, then grew by 0.16% to $14.4 million in 2018, then rose by 11.8% to $16.2 million in 2019, then rose by 21.36% to $19.6 million in 2020.
• Per Business Quant, the three latest ONC Minority Interest figures stand at $19.6 million (Q3 2020), $10.2 million (Q2 2020), and $14.8 million (Q1 2020).

Peer Comparison